Hippo Quarterly Balance Sheets Chart
Quarterly
|
Annual
Hippo Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||
| investments: | ||||||||||||||||||
| fixed maturities available-for-sale, at fair value | 237,300,000 | 212,200,000 | 205,700,000 | 201,800,000 | 167,000,000 | 162,700,000 | 161,700,000 | 141,500,000 | 135,600,000 | 141,000,000 | 121,100,000 | 109,200,000 | 102,600,000 | 86,500,000 | 54,900,000 | 59,700,000 | ||
| short-term investments, at fair value | 167,800,000 | 175,400,000 | 167,600,000 | 152,500,000 | 148,500,000 | 124,700,000 | 188,500,000 | 228,800,000 | 290,400,000 | |||||||||
| total investments | 405,100,000 | 387,600,000 | 373,300,000 | 354,300,000 | 315,500,000 | 287,400,000 | 348,800,000 | 330,000,000 | 364,400,000 | 431,400,000 | 445,900,000 | 330,800,000 | 454,300,000 | 435,400,000 | 64,000,000 | 72,000,000 | ||
| cash and cash equivalents | 198,900,000 | 140,900,000 | 197,600,000 | 191,200,000 | 175,900,000 | 223,400,000 | 142,100,000 | 228,400,000 | 200,200,000 | 188,900,000 | 194,500,000 | 346,500,000 | 277,500,000 | 336,800,000 | 775,600,000 | 778,700,000 | ||
| restricted cash | 26,900,000 | 39,300,000 | 35,200,000 | 39,700,000 | 44,300,000 | 39,900,000 | 53,000,000 | 41,000,000 | 38,200,000 | 31,800,000 | 50,000,000 | 46,400,000 | 47,000,000 | 44,800,000 | 43,100,000 | 44,100,000 | ||
| accounts receivable | 227,100,000 | 172,800,000 | 167,000,000 | 157,800,000 | 167,400,000 | 153,800,000 | 145,200,000 | 145,400,000 | 148,200,000 | 133,600,000 | 107,200,000 | 89,800,000 | 66,600,000 | 61,000,000 | 56,500,000 | 60,300,000 | ||
| reinsurance recoverable on paid and unpaid losses and lae | 302,600,000 | 326,000,000 | 285,300,000 | 279,800,000 | 290,800,000 | 290,100,000 | 281,300,000 | 297,300,000 | 332,700,000 | 300,600,000 | 286,300,000 | 337,300,000 | 291,400,000 | 321,400,000 | 266,900,000 | 279,400,000 | ||
| prepaid reinsurance premiums | 296,400,000 | 249,300,000 | 274,200,000 | 292,300,000 | 291,300,000 | 275,300,000 | 335,600,000 | 375,500,000 | 375,200,000 | 326,800,000 | 309,900,000 | 301,600,000 | 263,400,000 | 236,000,000 | 231,600,000 | 228,100,000 | ||
| ceding commissions receivable | 107,700,000 | 85,700,000 | 79,500,000 | 89,000,000 | 81,700,000 | 82,200,000 | 73,800,000 | 79,900,000 | 70,100,000 | 59,900,000 | 45,800,000 | 56,300,000 | 50,000,000 | 49,200,000 | 41,600,000 | 38,000,000 | ||
| capitalized internal use software | 47,200,000 | 47,400,000 | 48,100,000 | 50,200,000 | 49,900,000 | 48,900,000 | 48,400,000 | 46,900,000 | 44,000,000 | 41,200,000 | 38,800,000 | 36,800,000 | 34,000,000 | 30,300,000 | 25,900,000 | 21,600,000 | ||
| intangible assets | 14,300,000 | 16,100,000 | 17,000,000 | 23,800,000 | 25,000,000 | 26,200,000 | 27,300,000 | 23,600,000 | 24,700,000 | 25,800,000 | 26,900,000 | 28,000,000 | 29,200,000 | 30,300,000 | 32,200,000 | 33,700,000 | ||
| assets held for sale | 4,700,000 | |||||||||||||||||
| other assets | 75,300,000 | 75,300,000 | 66,200,000 | 67,300,000 | 68,500,000 | 69,100,000 | 69,200,000 | 79,000,000 | 83,100,000 | 64,700,000 | 63,600,000 | 56,500,000 | 62,500,000 | 75,800,000 | 51,800,000 | 49,100,000 | ||
| total assets | 1,706,200,000 | 1,540,400,000 | 1,543,400,000 | 1,545,400,000 | 1,510,300,000 | 1,496,300,000 | 1,524,700,000 | 1,647,000,000 | 1,680,800,000 | 1,604,700,000 | 1,568,900,000 | 1,630,000,000 | 1,629,400,000 | 1,674,500,000 | 1,642,700,000 | 1,658,200,000 | 230,905,463 | 231,219,945 |
| liabilities and stockholders’ equity | ||||||||||||||||||
| liabilities: | ||||||||||||||||||
| loss and loss adjustment expense reserve | 389,000,000 | 400,800,000 | 350,000,000 | 351,100,000 | 346,900,000 | 336,600,000 | 322,500,000 | 359,900,000 | 367,600,000 | 305,200,000 | 293,800,000 | 321,500,000 | 268,800,000 | 282,400,000 | 260,800,000 | 239,700,000 | ||
| unearned premiums | 506,200,000 | 446,000,000 | 457,900,000 | 473,800,000 | 452,700,000 | 407,300,000 | 419,200,000 | 441,800,000 | 423,100,000 | 365,700,000 | 341,300,000 | 316,500,000 | 282,900,000 | 252,100,000 | 253,100,000 | 244,300,000 | ||
| reinsurance premiums payable | 302,900,000 | 238,300,000 | 248,600,000 | 261,200,000 | 246,600,000 | 263,200,000 | 260,100,000 | 291,100,000 | 302,700,000 | 249,500,000 | 207,100,000 | 215,900,000 | 192,400,000 | 201,700,000 | 159,400,000 | 162,100,000 | ||
| benefit from commission | 38,400,000 | 38,700,000 | 34,300,000 | 31,100,000 | 31,300,000 | 29,000,000 | 24,700,000 | 18,000,000 | 12,700,000 | 8,700,000 | 5,000,000 | 13,400,000 | 13,300,000 | 14,400,000 | 12,300,000 | 11,200,000 | ||
| surplus note | 47,900,000 | |||||||||||||||||
| liabilities held for sale | 10,500,000 | |||||||||||||||||
| accrued expenses and other liabilities | 77,200,000 | 90,900,000 | 87,400,000 | 98,100,000 | 106,200,000 | 105,400,000 | 113,500,000 | 124,900,000 | 127,700,000 | 132,600,000 | 128,200,000 | 123,700,000 | 120,600,000 | 101,100,000 | 83,800,000 | 61,900,000 | ||
| total liabilities | 1,372,100,000 | 1,214,700,000 | 1,178,200,000 | 1,215,300,000 | 1,183,700,000 | 1,141,500,000 | 1,140,000,000 | 1,235,700,000 | 1,233,800,000 | 1,061,700,000 | 975,400,000 | 991,000,000 | 878,000,000 | 865,800,000 | 781,000,000 | 754,500,000 | 26,151,898 | 23,834,287 |
| commitments and contingencies | ||||||||||||||||||
| stockholders’ equity: | ||||||||||||||||||
| common stock | ||||||||||||||||||
| additional paid-in capital | 1,653,700,000 | 1,646,000,000 | 1,639,700,000 | 1,645,100,000 | 1,636,800,000 | 1,624,700,000 | 1,615,200,000 | 1,606,100,000 | 1,590,900,000 | 1,574,700,000 | 1,558,000,000 | 1,540,800,000 | 1,522,800,000 | 1,504,400,000 | 1,488,300,000 | 1,469,100,000 | 11,565,268 | 8,933,205 |
| accumulated other comprehensive income | 100,000 | -700,000 | -400,000 | |||||||||||||||
| accumulated deficit | -1,321,300,000 | -1,322,600,000 | -1,274,900,000 | -1,319,200,000 | -1,310,600,000 | -1,270,100,000 | -1,234,400,000 | -1,192,000,000 | -1,138,900,000 | -1,031,100,000 | -961,100,000 | -898,000,000 | -768,800,000 | -695,600,000 | -628,000,000 | -567,300,000 | -6,566,141 | -3,934,048 |
| total hippo stockholders’ equity | 332,500,000 | 322,800,000 | 326,400,000 | 322,600,000 | 351,200,000 | 407,000,000 | 445,600,000 | 538,300,000 | 635,000,000 | 749,100,000 | 805,500,000 | |||||||
| noncontrolling interest | 1,600,000 | 2,900,000 | 3,100,000 | 3,700,000 | 4,000,000 | 3,600,000 | 6,800,000 | 4,300,000 | 1,400,000 | 4,700,000 | 3,600,000 | 4,000,000 | 2,300,000 | 3,200,000 | 2,100,000 | 2,300,000 | ||
| total stockholders’ equity | 334,100,000 | 325,700,000 | 365,200,000 | 330,100,000 | 326,600,000 | 354,800,000 | 384,700,000 | 411,300,000 | 447,000,000 | 543,000,000 | 593,500,000 | 639,000,000 | 751,400,000 | 808,700,000 | 861,700,000 | 903,700,000 | ||
| total liabilities and stockholders’ equity | 1,706,200,000 | 1,540,400,000 | 1,543,400,000 | 1,545,400,000 | 1,510,300,000 | 1,496,300,000 | 1,524,700,000 | 1,647,000,000 | 1,680,800,000 | 1,604,700,000 | 1,568,900,000 | 1,630,000,000 | 1,629,400,000 | 1,674,500,000 | ||||
| accumulated other comprehensive loss | -600,000 | -2,700,000 | 500,000 | -3,600,000 | -3,400,000 | -2,900,000 | -7,100,000 | -6,400,000 | -5,300,000 | -7,000,000 | -7,800,000 | -4,900,000 | -3,300,000 | |||||
| stockholders’ equity | ||||||||||||||||||
| total hippo stockholders' equity | 362,100,000 | 377,900,000 | 589,900,000 | 859,600,000 | 901,400,000 | |||||||||||||
| short-term investments | 187,100,000 | 324,800,000 | 221,600,000 | 351,700,000 | 348,900,000 | 9,100,000 | 12,300,000 | |||||||||||
| goodwill | 53,500,000 | 53,500,000 | 53,500,000 | 53,200,000 | ||||||||||||||
| contingent consideration liability | 14,100,000 | 11,600,000 | 11,500,000 | |||||||||||||||
| liabilities, convertible preferred stock, and stockholders’ equity | ||||||||||||||||||
| convertible promissory notes | ||||||||||||||||||
| derivative liability on notes | ||||||||||||||||||
| preferred stock warrant liabilities | ||||||||||||||||||
| convertible preferred stock: | ||||||||||||||||||
| preferred stock, 0.0001 par value per share; 10,000,000 and 323,232,460 shares authorized as of december 31, 2021 and december 31, 2020, respectively; 0 and 305,887,443 shares issued and outstanding as of december 31, 2021 and december 31, 2020, respectively; liquidation preferences of 0 and 359.4 million as of december 31, 2021 and december 31, 2020, respectively | ||||||||||||||||||
| total liabilities, convertible preferred stock, and stockholders’ equity | 1,642,700,000 | 1,658,200,000 | ||||||||||||||||
| fiduciary liabilities | 23,800,000 | |||||||||||||||||
| preferred stock, 0.0001 par value per share; 10,000,000 and 323,232,460 shares authorized as of september 30, 2021 and december 31, 2020, respectively; 0 and 305,887,443 shares issued and outstanding as of september 30, 2021 and december 31, 2020, respectively; liquidation preferences of 0 and 359.4 million as of september 30, 2021 and december 31, 2020, respectively | ||||||||||||||||||
| assets: | ||||||||||||||||||
| current assets: | ||||||||||||||||||
| cash | 101,045 | 214,015 | ||||||||||||||||
| prepaid expenses | 800,310 | 934,320 | ||||||||||||||||
| total current assets | 901,355 | 1,148,335 | ||||||||||||||||
| cash and investments held in trust account | 230,004,108 | 230,071,610 | ||||||||||||||||
| liabilities and shareholders’ equity: | ||||||||||||||||||
| current liabilities: | ||||||||||||||||||
| accounts payable | 89,189 | 22,500 | ||||||||||||||||
| accrued expenses | 874,866 | 866,866 | ||||||||||||||||
| due to related party | 334,663 | 168,661 | ||||||||||||||||
| total current liabilities | 1,298,718 | 1,058,027 | ||||||||||||||||
| deferred legal fees | 200,000 | 200,000 | ||||||||||||||||
| deferred underwriting commissions | 8,050,000 | 8,050,000 | ||||||||||||||||
| derivative warrant liabilities | 16,603,180 | 14,526,260 | ||||||||||||||||
| class a ordinary shares; 19,975,356 and 20,484,749 shares subject to possible redemption at 10.00 per share at june 30, 2021 and december 31, 2020, respectively | 199,753,560 | |||||||||||||||||
| shareholders’ equity: | ||||||||||||||||||
| preference shares, 0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | ||||||||||||||||||
| class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized; 3,024,644 and 2,515,251 shares issued and outstanding (excluding 19,975,356 and 20,484,749 shares subject to possible | 303 | |||||||||||||||||
| redemption) at june 30, 2021 and december 31, 2020, respectively | ||||||||||||||||||
| class b ordinary shares, 0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding at june 30, 2021 and december 31, 2020 | 575 | |||||||||||||||||
| total shareholders’ equity | 5,000,005 | 5,000,008 | ||||||||||||||||
| total liabilities and shareholders’ equity | 230,905,463 | 231,219,945 | ||||||||||||||||
| class a ordinary shares; 20,238,565 and 20,484,749 shares subject to possible redemption at 10.00 per share at march 31, 2021 and december 31, 2020, respectively | 202,385,650 | |||||||||||||||||
| class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized; 2,761,435 and 2,515,251 shares issued and outstanding (excluding 20,238,565 and 20,484,749 shares subject to possible redemption) at march 31, 2021 and december 31, 2020, respectively | 276 | |||||||||||||||||
| class b ordinary shares, 0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding at march 31, 2021 and december 31, 2020 | 575 |
We provide you with 20 years of balance sheets for Hippo stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Hippo. Explore the full financial landscape of Hippo stock with our expertly curated balance sheets.
The information provided in this report about Hippo stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.